• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Super-Charged Digital Triage Brings Consultants to GP Appointments

Share:

May 27, 2020

Cinapsis aims to ease the burden with enhanced digital triage that allows GPs to call in consultants for real-time primary care decisions.

Gloucestershire Hospitals NHS trust, in the UK, has reduced unnecessary referrals to A&E by up to 83% since installing Cinapsis, a digital triage platform that could help UK hospitals tackle the consultation backlog that has built up during the COVID-19 pandemic.

Cinapsis allows GPs to ‘beam in’ consultants via an app, maintaining specialist support while reducing the need for hospital visits, and enabling A&E trips to be triaged in advance.

Beginning with GP practices, the platform has been rolled-out across the One Gloucestershire partnership since December 2018. Seventy per cent of dermatology referrals have been managed without a face-to-face hospital appointment as a result. Since the coronavirus outbreak, 32% of patients with COVID-19 have been cared for safely at home – relieving the pressure on hospitals.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

GPs use ‘smart referrals’ via the app to contact consultants who can then offer advice via voice, video, image sharing or messaging – meaning that only patients who need further clinical support are referred for physical appointments.

Founder of Cinapsis, ENT surgeon Dr Owain Rhys Hughes, said the concept of the platform was based on understanding the importance of strengthening existing relationships within the healthcare network.

“GPs want to talk to clinicians in their local hospital,” he said. “They want advice, and advice on how to implement it within their own health system.”

Dr Hughes said enabling easier collaboration between GPs, emergency healthcare workers and specialist means that decisions can be made quickly and seamlessly.

“This is crucial at a time when we run the risk of serious collateral damage in public health post-COVID-19,” he said. “There’s a significant backlog in the system for specialist treatments and appointments, so we’re putting consultants in the hands of GPs to speed up the process, so long waits and longer waiting lists can be completely avoided.”

A number of other trusts are currently in the process of adopting the platform.

WHAT’S THE IMPACT

Cinapsis is designed to help both GPS and clinicians with their day-to-day work but Dr Hughes acknowledged that acute medical consultants – already under considerable pressure – might initially wonder what’s in it for them.

“We needed to address their pain-points,” he said. “Their unpredictable workload – not knowing when a referred patient might turn up in A&E, but aware that they’d have to leave their own department to see them, perhaps even at the end of a busy shift.

“Cinapsis gives them control of their workload from primary care. They can defer patients who can wait, call in those who need to attend A&E, convert others to planned care so they will be seen in an environment where the patient is expected.”

WHAT’S THE TREND

Dr Hughes said Cinapsis is a pragmatic solution to many of the problems that are arising from COVID-19. Patients are anxious about attending hospital appointments in person. In the ‘new normal’, hospitals will have to operate with social distancing – reducing capacity and slowing throughput.

“The most important thing in building a technology platform like this is empathy,” he said. “You have to listen to what people are telling you. We sit between organisations and people who work differently within the same network – and we had to listen to both sides to understand what would help them.

“They all really want to do their best for the patient – and they work remarkably well together. This just allows them to do things more efficiently.”

ON THE RECORD

“Not only are we helping to reassure and better manage our patients by giving them the benefit of specialist advice, we are also reducing demand on busy hospitals by making properly informed decisions,” said Dr Malcolm Gerald, lead GP on the Cinapsis project in Gloucestershire.

“Our data shows that following discussion with a specialist, around a third of COVID-19 patients whose referring clinician had significant concerns about them did not need to be admitted to hospital. This has reduced unnecessary patient, family and staff exposure to the virus, whilst keeping important bed space free for those most in need.”

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • American Cancer Society and Color Health Partner to Provide Free Lung Cancer ScreeningAmerican Cancer Society and Color Health Partner to Provide Free Lung Cancer Screening
  • AbbVie Completes Transformative Acquisition of AllerganAbbVie Completes Transformative Acquisition of Allergan
  • Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-upAccord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-up
  • Cytovale Secures $84M for Transformative Sepsis Diagnostic ToolCytovale Secures $84M for Transformative Sepsis Diagnostic Tool
  • Purolite Announces Retention of Evercore Group L.L.C. to Explore Strategic Acquisitions in its Healthcare and Life Sciences SegmentPurolite Announces Retention of Evercore Group L.L.C. to Explore Strategic Acquisitions in its Healthcare and Life Sciences Segment
  • Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptimaGenesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
  • Credentialing Platform Medallion Raises $35M and More Digital Health FundingsCredentialing Platform Medallion Raises $35M and More Digital Health Fundings
  • Ankylosing Spondylitis Pipeline Market Report 2021Ankylosing Spondylitis Pipeline Market Report 2021

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications